Matthew Pauls - 10 Dec 2025 Form 4 Insider Report for Pelthos Therapeutics Inc. (CHRO)

Reporting relationship: Director
Issuer ticker: CHRO
Reported as of: 10 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Dec 2025, 17:01:02 UTC
Prior SEC filing: 11 Dec 2025
Next SEC filing: 16 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Matthew Pauls

Key filing fact

Matthew Pauls filed Form 4 for Pelthos Therapeutics Inc. (CHRO) on 12 Dec 2025.

Key facts

This page summarizes Matthew Pauls's Form 4 filing for Pelthos Therapeutics Inc. (CHRO).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 12 Dec 2025, 17:01.

Change

Previous filing in this sequence was filed on 11 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001573429 Primary reporting owner

Pauls Matthew

Relationship: Director
Address: C/O PELTHOS THERAPEUTICS INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM
Signature: /s/ Matthew Pauls
Signature date: 12 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PTHS transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +8,493
Change %
Price: $0.000000
Shares after: 8,493
Date: 02 Jul 2025
Ownership: Direct
Footnotes: F1

PTHS transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +2,123
Change %: +25%
Price: $0.000000
Shares after: 10,616
Date: 02 Oct 2025
Ownership: Direct
Footnotes: F1

PTHS transaction

Common Stock

Gift

Transaction value: $0
Shares: -9,542
Change %: -90%
Price: $0.000000
Shares after: 1,074
Date: 10 Dec 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PTHS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -8,493
Change %: -33%
Price: $0.000000
Shares after: 16,985
Date: 02 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,493
Exercise price
Footnotes: F1, F3

PTHS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -2,123
Change %: -12%
Price: $0.000000
Shares after: 14,862
Date: 02 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,123
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units ("RSUs"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years.

Footnote F2

On December 10, 2025, the Reporting Person transferred 9,542 shares of Common Stock to GP 2024 Trust, U/A Dated, 12/20/2024, for no consideration. The Reporting Person is not a trustee and does not retain investment or voting control over the shares. Following the gift, the Reporting Person disclaims beneficial ownership of the shares held by the Trust and reports beneficial ownership herein only to the extent of any pecuniary interest, if any.

Footnote F3

Each RSU represents a contingent right to receive one share of issuer's Common Stock.